As a doctor, your hourly wage towers over the average American worker. Some of you are pulling in $1,000 an hour—pretty competitive, right? After grinding through 4 years of college, 4 years of medical school, 8 years of residency, and tackling a mountain of student loans, you’ve earned it. Once you’ve climbed the ladder to...
As doctors, we weigh therapeutic benefits against risks before prescribing any treatment. We analyze data, assess outcomes, and proceed only when the potential for healing outweighs the harm. Biotech investing follows a similar logic: you evaluate potential profits against possible losses, seeking an imbalance (outsized) rewards-to-risk profile. Small-cap growth biotech stocks offer a unique opportunity....
Docs, Let me ask you something straight-up: Have you ever bought a stock, watched it tank, and sworn off investing for good? If you nodded yes, you’re in good company. Plenty of new investors have been burned by a bad pick and felt the sting so deeply they walked away from the market entirely. But...
As a doctor or healthcare pro, you’re used to making high-stakes calls with precision and confidence. Lives depend on it. But when it comes to investing, doubt can creep in, making you second-guess your moves. That’s where Peter Lynch’s wisdom hits home: “Just because a stock is going up doesn’t mean you’re right. Just because...
Doc, let me ask you this: what pops into your head when you hear “neuroleptics” (you know, those drugs used to treat schizophrenia)? I bet you’re thinking most neuroleptics can handle positive symptoms like hallucinations pretty well, but negative symptoms? That’s a tougher nut to crack. We’re talking flat affect, lack of motivation, and the...
The digital revolution has flooded the internet with a vast amount of information, but more data doesn’t guarantee investment success. The key is high-quality information. That’s why I turn to the timeless wisdom of iconic investors like John Templeton, Warren Buffett, and his mentors, Ben Graham and Phil Fisher, adapting their principles to biotech investing....
Continuing the theme of this blog, doctors and healthcare professionals have a unique edge in biotech investing, but you need to integrate that insight into a robust investing framework. This newsletter serves to help you with that integration. So, if you haven’t read my prior article on this topic, I encourage you to check it...
Yesterday, I shared Why Physicians and Healthcare Providers Make Great Biotech Investors. The takeaway? As a physician, your deep medical and scientific training puts you on the front lines of clinical care, giving you a unique edge in spotting breakthrough developments before they hit the radar. Here’s a perfect example that proves it. I recently...
As physicians and healthcare providers, you’ve spent years in medical school and clinical practice mastering medicine, biostatistics, and more. But let’s be real—investing and finance? Those weren’t part of the curriculum. So, you might think biotech investing is out of your league, something reserved for Wall Street wizards. That’s conventional wisdom. And it’s dead wrong....
The Berkshire Hathaway 2025 Annual Meeting held on May 3, 2025 marked the end of an era—and the beginning of a new chapter. Warren Buffett confirmed he will step down as CEO by the end of 2025, handing over the reins to Greg Abel, a proven leader with Buffett’s full confidence. Though stepping aside, Buffett...